Immediate Impact
46 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Works of Otto van Delden being referenced
Gadoxetic acid uptake as a molecular imaging biomarker for sorafenib resistance in patients with hepatocellular carcinoma: a post hoc analysis of the SORAMIC trial
2021
Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Otto van Delden | 223 | 189 | 127 | 137 | 34 | 474 | |
| David M. Sella | 215 | 142 | 122 | 55 | 36 | 450 | |
| Shintaro Shirai | 173 | 210 | 188 | 68 | 40 | 548 | |
| Olaguoke Akinwande | 174 | 291 | 291 | 155 | 41 | 553 | |
| Alessandro Posa | 173 | 145 | 176 | 66 | 55 | 460 | |
| Andreas Y. Andreou | 158 | 216 | 95 | 116 | 53 | 427 | |
| Xiaoli Zhu | 119 | 95 | 263 | 76 | 37 | 428 | |
| H. Rieß | 76 | 127 | 170 | 66 | 28 | 470 | |
| Guido Fiorentini | 282 | 390 | 222 | 276 | 54 | 570 | |
| Sadeer Alzubaidi | 122 | 184 | 126 | 42 | 32 | 448 | |
| Mario Corona | 258 | 221 | 132 | 51 | 38 | 425 |
All Works
Loading papers...